{"id":"W4416015139","doi":"10.1007/s41669-025-00610-1","title":"Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis","year":2025,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; ABB (Canada); CancerCare Manitoba; University of Calgary","funders":"","keywords":"Venetoclax; Obinutuzumab; Ven; Chronic lymphocytic leukemia; Ibrutinib; Bendamustine; IGHV@; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004795838,0.001156444,0.001757408,0.002003405,0.0006490079,0.001609889,0.001499959,0.000771104,0.003551308],"category_scores_gemma":[0.01136445,0.0005145935,0.005028206,0.003264675,0.0005077619,0.0005135706,0.0006952208,0.001334624,0.0001240876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04120287,"about_ca_system_score_gemma":0.02218561,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8743008,"about_ca_topic_score_gemma":0.8548195,"domain_scores_codex":[0.9982768,0.0009314111,0.00006898584,0.0001301735,0.0003526864,0.0002398819],"domain_scores_gemma":[0.9955208,0.002845733,0.0004139591,0.0001448178,0.0007070851,0.0003675694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.0322,0.001280048,0.1225531,0.006013561,0.02629948,0.001006756,0.0003173884,0.6742672,0.00104411,0.009349244,0.0172892,0.1083799],"study_design_scores_gemma":[0.01525905,0.004530946,0.1497959,0.002365538,0.03927284,0.0009382462,0.0007063785,0.7557669,0.0007855917,0.006636002,0.02354292,0.0003996424],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8980718,0.0537565,0.00554022,0.003715812,0.0001274187,0.001494076,0.01996998,0.0001261821,0.01719803],"genre_scores_gemma":[0.9857103,0.00585243,0.002910074,0.0003086462,0.00002786098,0.0001573053,0.00392637,0.00002122031,0.001085921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1256992,"threshold_uncertainty_score":0.2989492,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01948353024040585,"score_gpt":0.3295830902794832,"score_spread":0.3100995600390773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}